International Clinical Trial: To confirm the safety and performance of MDC-75 in individuals with benign superficial skin lesions

Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ISRCTN16760053) titled 'To confirm the safety and performance of MDC-75 in individuals with benign superficial skin lesions' on June 30.

Study Type: Interventional

Study Design: Prospective unicentric open-label study (Safety, Efficacy)

Primary Sponsor: R&D Pharma

Condition: Superficial benign skin lesions: seborrheic keratosis, common warts, benign dermic naevi, acrochordons (including fibroid pendulum), or isolated low-grade actinic keratosis Skin and Connective Tissue Diseases

Intervention: This is a prospective unicentric open-label study to demonstrate the safety and clinical benefits of MDC-75 when applied to isolated low-gr...